Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Comparative Medicine ; (6): 88-94, 2018.
Artigo em Chinês | WPRIM | ID: wpr-703347

RESUMO

Objective To analyze the effect of a Chinese medicine Zhengqingfengtongning on the expression of aggrecanase-1(ADAMTs-4)and aggrecanase-2(ADAMTs-5)in cartilage tissue of knee joint in rabbit models of osteoarthritis,and to study the mechanism of action of Zhengqingfengtongning in treatment for osteoarthritis. Methods 32 New Zealand rabbits were randomly divided into the observation group and the model group, and 16 healthy New Zealand rabbits were chosen as the blank group. The blank group did not receive the intervention treatment, the model group received physiological saline in gastric gavage, the observation group was given the Zhengqingfengtongning by gastric gavage. The soft tissue samples of knee joint in the three groups were taken at 4 weeks after drug intervention. The joint morphology,joint fluid and articular cartilage were observed by histopathology. The ADAMTs-4 and ADAMTs-5 mRNA were detected by RT-PCR. The data were then statistically analyzed. Results The grades of articular cartilage and Mankin's score of the model group were significantly higher than those of the observation group and blank group,the grades of articular cartilage and Mankin's score of the observation group were significantly higher than those of the blank group, and the difference between the two groups was statistically significant(P< 0.05). The ADAMTs-4 and ADAMTs-5 mRNA expressions of the model group were significantly higher than those of the observation group and blank group. The ADAMTs-4 and ADAMTs-5 mRNA expressions of the observation group were significantly higher than those of the blank group, and the difference between the two groups was statistically significant(P< 0.05). Conclusions The Zhengqingfengtongning can improve the degree of joint lesions in osteoarthritis animal models,which may be related to inhibiting the expression of ADAMTs-4 and ADAMTs-5.

2.
Chinese Pharmaceutical Journal ; (24): 96-99, 2017.
Artigo em Chinês | WPRIM | ID: wpr-858834

RESUMO

Search Chinese search CNKI, VIP full-text database and MML (Metadata center of Medical Literature) about the document of the Zhengqingfengtongning Injection adverse drug reaction and the effect of Zhengqingfengtongning Injection in enhancing efficacy and reducing toxicity of chemotherapy. To analyze the correlation between dosage, mode of administration, time and ADR occurrence. To summarize the synergistic and attenuated drugs, and explore the mechanism of interaction between Zhengqingfengtongning Injection and these synergistic and attenuated drugs. Discuss the mechanism of Zhengqingfengtongning Injection ADR and the mechanism of Zhengqingfengtongning Injection's synergism and attenuation, and preventive measures of the ADR. The purpose of this paper is to provide evidence basis for clinical safety of the application of Zhengqingfengtongning Injection.

3.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 3452-3455, 2016.
Artigo em Chinês | WPRIM | ID: wpr-504246

RESUMO

Objective To observe the curative effect of Zhengqingfengtongning release tablets and lumbroki-nase enteric -coated capsules and losartan potassium tablets joint for the treatment of chronic nephritis proteinuria, and explore its mechanism.Methods 42 patients with chronic nephritis were randomly divided into two groups. 20 cases in the control group were given losartan potassium tablets,50mg,1 ~2 times a day.22 cases in the treatment group received Zhengqingfengtongning release tablets 120mg,2 times a day,lumbrokinase enteric -coated capsules 600 000u,3 times a day on the basis of the control group.The 24h urine protein,liver and kidney function before and after the treatment were observed.Results 20 days after treatment,24h urinary protein in the treatment group decreased 57.08%,which in the control group decreased 41.59%,the difference was statistically significant (t =2.39,P <0.05).30 days after treatment,24h urinary protein in the treatment group decreased 81.28%,which in the control group decreased 52.34%,the difference was statistically significant (t =3.65,P <0.01 ).Renal function change had no significant difference between the two groups.Conclusion Zhengqingfengtongning release tablets and lumbrokinase enteric -coated capsules combined with losartan potassium tablets in the treatment of chronic nephritis proteinuria work fast,and has good curative effect,less side effects,and is worth to recommend.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA